Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 68180-614

11 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 68180-614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 01)

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 01)
Chemical structure diagram depicting the active ingredient Quetiapine and its associated molecular components, showing detailed atomic connections and groupings as part of its extended release pharmaceutical formulation.*
FDA Label Image

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 02)

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 02)
A Kaplan-Meier curve graph depicting the time to schizophrenic relapse over 7 months. The y-axis shows the proportion of patients with relapse in percent, and the x-axis shows time in months. Two curves compare placebo (PLA) and Quetiapine extended-release (QTP XR), illustrating differences in relapse rates between the groups over time.*
FDA Label Image

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 03)

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 03)
A Kaplan-Meier curve chart showing time to recurrence of a mood event over weeks. The y-axis represents the proportion of patients with relapse (%), and the x-axis shows time in weeks. Two curves are shown comparing QTP + LIWAL and PLA + LIWAL groups, illustrating differences in relapse rates over a 100-week period.*
FDA Label Image

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 04)

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 04)
Kaplan-Meier curves graph showing the proportion of patients with relapse (%) over time in weeks. The graph compares two groups: QTP+LIVAL and PLA+LIVAL, depicting time to recurrence of a mood event in Study 10. The x-axis represents time in weeks, and the y-axis represents the proportion of patients relapsing.*
FDA Label Image

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 699 1)

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 699 1)
Quetiapine 150 mg extended-release film-coated tablets by Lupin Pharmaceuticals, Inc. The image shows a white and green blister pack containing 14 tablets arranged in two rows of seven each. The tablets are round and embossed with the number '150.'*
FDA Label Image

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 759 1)

Image (486bd7e7 86bb 44cb 98fc 33584ddcfe98 759 1)
Quetiapine 50 mg extended-release film-coated tablets carton from Lupin Pharmaceuticals, Inc., showing a package containing 30 tablets. The label includes the product name, strength, dosage form, and the manufacturer name.*
FDA Label Image

01 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 05)

01 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 05)
Label for Quetiapine Extended-Release Tablets USP, 50 mg, oral film-coated tablets. The label shows it is for once daily use, with each tablet containing 58 mg quetiapine fumarate USP equivalent to 50 mg quetiapine. The package contains 60 tablets and is manufactured by Lupin Pharmaceuticals, Inc. and Lupin Limited in India. Storage instructions and a QR code for medication guide access are also shown.*
FDA Label Image

02 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 06)

02 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 06)
Label for Quetiapine Extended-Release Tablets USP 150 mg by Lupin Pharmaceuticals, Inc. The label states the dosage form as film-coated tablets, extended release, for oral use, with a recommended once-daily dose. It contains 60 tablets per package. The label includes storage instructions, manufacturer information for Lupin Pharmaceuticals in the US and Lupin Limited in India, a barcode, and a QR code linking to the medication guide.*
FDA Label Image

03 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 07)

03 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 07)
Label for Quetiapine Extended-Release Tablets USP, 200 mg, film-coated tablets in a 60-tablet package. The label indicates once-daily oral dosing, manufacturing by Lupin Pharmaceuticals, Inc., and includes storage instructions and a barcode. The product is made in India and distributed by Lupin Pharmaceuticals, Inc.*
FDA Label Image

04 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 08)

04 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 08)
Label for Quetiapine Extended-Release Tablets USP 300 mg oral film-coated tablets by Lupin Pharmaceuticals, Inc. The label indicates 60 tablets per container, with directions for once daily use. It includes storage instructions and manufacturing details, along with an NDC of 68180-615-07 and barcode.*
FDA Label Image

05 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 09)

05 (486bd7e7 86bb 44cb 98fc 33584ddcfe98 09)
Label for Quetiapine Extended-Release Tablets USP 400 mg, oral film-coated extended-release tablets. The package contains 60 tablets. Manufactured for Lupin Pharmaceuticals, Inc. The label includes dosage instructions, storage information, and a barcode. Manufactured by Lupin Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.